CA2304869A1 - Traitement medical au moyen d'acide urique ou de precurseurs connexes - Google Patents
Traitement medical au moyen d'acide urique ou de precurseurs connexes Download PDFInfo
- Publication number
- CA2304869A1 CA2304869A1 CA002304869A CA2304869A CA2304869A1 CA 2304869 A1 CA2304869 A1 CA 2304869A1 CA 002304869 A CA002304869 A CA 002304869A CA 2304869 A CA2304869 A CA 2304869A CA 2304869 A1 CA2304869 A1 CA 2304869A1
- Authority
- CA
- Canada
- Prior art keywords
- uric acid
- cancer
- precursor
- acid
- mammal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002304869A CA2304869A1 (fr) | 2000-04-07 | 2000-04-07 | Traitement medical au moyen d'acide urique ou de precurseurs connexes |
CA002405591A CA2405591A1 (fr) | 2000-04-07 | 2001-04-04 | Utilisation d'acide urique ou de precurseurs de celui-ci comme traitement du cancer, du sida et analogue |
AU2001248173A AU2001248173A1 (en) | 2000-04-07 | 2001-04-04 | Use of uric acid or precursors thereof as a treatment for cancer, aids and the like |
PCT/CA2001/000457 WO2001076606A2 (fr) | 2000-04-07 | 2001-04-04 | Utilisation d'acide urique ou de precurseurs de celui-ci comme traitement du cancer, du sida et analogue |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002304869A CA2304869A1 (fr) | 2000-04-07 | 2000-04-07 | Traitement medical au moyen d'acide urique ou de precurseurs connexes |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2304869A1 true CA2304869A1 (fr) | 2001-10-07 |
Family
ID=4165836
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002304869A Abandoned CA2304869A1 (fr) | 2000-04-07 | 2000-04-07 | Traitement medical au moyen d'acide urique ou de precurseurs connexes |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2001248173A1 (fr) |
CA (1) | CA2304869A1 (fr) |
WO (1) | WO2001076606A2 (fr) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5508031A (en) * | 1986-11-21 | 1996-04-16 | Cetus Oncology Corporation | Method for treating biological damage using a free-radial scavenger and interleukin-2 |
WO1997039352A1 (fr) * | 1996-04-15 | 1997-10-23 | Fox Chase Cancer Center | Methodes de detection de metabolites de purine |
US5872124A (en) * | 1996-07-31 | 1999-02-16 | Thomas Jefferson University | Treatment of diseases of the central nervous system using uric acid as a scavenger of peroxynitrite |
ATE352306T1 (de) * | 1998-07-31 | 2007-02-15 | Meir S Sacks | Ein präkursor der harnsäure und ein antioxidationsmittel enthaltende zusammensetzung und deren verwendung zur behandlung von neurodegenerativen erkrankungen |
-
2000
- 2000-04-07 CA CA002304869A patent/CA2304869A1/fr not_active Abandoned
-
2001
- 2001-04-04 AU AU2001248173A patent/AU2001248173A1/en not_active Abandoned
- 2001-04-04 WO PCT/CA2001/000457 patent/WO2001076606A2/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2001076606A2 (fr) | 2001-10-18 |
AU2001248173A1 (en) | 2001-10-23 |
WO2001076606A3 (fr) | 2002-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN114641293B (zh) | 一种fgfr抑制剂的用途 | |
CA3134156C (fr) | Chiauranib pour le traitement du cancer du poumon a petites cellules | |
Campbell et al. | Acute reactions to mega ascorbic acid therapy in malignant disease | |
CN112274507A (zh) | NAT10的小分子抑制剂remodelin在制备口腔鳞癌治疗药物中的应用 | |
WO2024088275A1 (fr) | Utilisation d'un composé naphtylamide dans le traitement de tumeurs résistantes aux médicaments | |
CA2304869A1 (fr) | Traitement medical au moyen d'acide urique ou de precurseurs connexes | |
CA2405591A1 (fr) | Utilisation d'acide urique ou de precurseurs de celui-ci comme traitement du cancer, du sida et analogue | |
Kostakopoulos et al. | Intravesical interferon alfa-2b administration in the treatment of superficial bladder tumors | |
WO2022221834A2 (fr) | Méthode de traitement du cancer du poumon et du cancer du poumon non à petites cellules | |
CN109481687B (zh) | 用于胃癌治疗的cdk4/6抑制剂联合her2抑制剂的组合 | |
Metzger et al. | Long-term complete remission of melanoma liver metastases after intermittent intra-arterial cisplatin chemotherapy and surgery | |
Kudo et al. | Leiomyosarcoma arising in the nasal cavity | |
CN106420789A (zh) | 复发耐药消化道肿瘤地西他滨综合治疗方案 | |
Ushigome et al. | Efficacy and safety of preoperative chemoradiotherapy with S-1 for advanced rectal cancer: a phase II study | |
CN114668757B (zh) | 土槿皮丙酸在制备预防和/或治疗恶性肿瘤药物中的应用 | |
Boudinar et al. | Clinico epidemiological and therapeutic profile of GIST: Oran center's experience | |
Seyed et al. | Perianal Mucinous Adenocarcinoma Found Incidentally From Perianal Mass | |
Takamatsu et al. | A case of metastatic carcinoid tumor of the pancreas resected by laparoscopic distal pancreatectomy | |
WO2024046405A1 (fr) | Utilisation d'inhibiteur de kinase egfr | |
WO2019196621A1 (fr) | Utilisation d'un composé de quinazoline dans un médicament pour le traitement de cancers avec mutation d'activation d'egfrv3 | |
Yue et al. | Tongue Squamous Cell Carcinoma in Younger Adult Female with a History of Breast Cancer: A Rare Case Report | |
Manal et al. | Primary Hepatic Squamous Cell Carcinoma: A Case Report | |
Lyagoubi et al. | Primary Hepatic Squamous Cell Carcinoma: A | |
WO2018072269A1 (fr) | Application d'un médicament anti-inflammatoire non stéroïdien pour augmenter la sensibilité d'une cellule tumorale à un inhibiteur de la tyrosine kinase | |
Zhu et al. | Effect of sequential gemcitabine and epirubicin therapy on high-risk non-muscle invasive bladder cancer following transurethral bladder tumour resection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |